Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Boller

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Critical Reviews in Oncology/Hematology|July 31, 2007
Targeting receptor tyrosine kinase signaling in acute myeloid leukemiaKathrin T Doepfner, Danielle Boller, Alexandre Arcaro
Drug News & Perspectives|August 31, 2006
IGF-IR: potential role in antitumor agentsAna S Guerreiro, Danielle Boller, Kathrin T Doepfner, et al.
International Journal of Cancer|September 22, 2006
Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibitionAna S Guerreiro, Danielle Boller, Tarek Shalaby, et al.
Recent Patents on DNA & Gene Sequences|December 17, 2008
Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discoveryKathrin T Doepfner, Danielle Boller, Angela De Laurentiis, et al.
Glia|October 6, 2005
Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferationSuzana Atanasoski, Danielle Boller, Lukas De Ventura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsDanielle Boller, Alexander Schramm, Kathrin T Doepfner, et al.
The Biochemical Journal|May 18, 2007
Novel role for insulin as an autocrine growth factor for malignant brain tumour cellsAlexandre Arcaro, Kathrin T Doepfner, Danielle Boller, et al.
Plos One|April 11, 2014
Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastomaKatrin Höland, Danielle Boller, Christian Hagel, et al.
Anticancer Research|July 31, 2012
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumoursDanielle Boller, Kathrin T Doepfner, Angela De Laurentiis, et al.
Anticancer Research|May 31, 2022
Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine TumoursDanielle Boller, Kathrin T Doepfner, Angela DE Laurentiis, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Reviews in Oncology/Hematology|July 31, 2007
Targeting receptor tyrosine kinase signaling in acute myeloid leukemiaKathrin T Doepfner, Danielle Boller, Alexandre Arcaro
Drug News & Perspectives|August 31, 2006
IGF-IR: potential role in antitumor agentsAna S Guerreiro, Danielle Boller, Kathrin T Doepfner, et al.
International Journal of Cancer|September 22, 2006
Protein kinase B modulates the sensitivity of human neuroblastoma cells to insulin-like growth factor receptor inhibitionAna S Guerreiro, Danielle Boller, Tarek Shalaby, et al.
Recent Patents on DNA & Gene Sequences|December 17, 2008
Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discoveryKathrin T Doepfner, Danielle Boller, Angela De Laurentiis, et al.
Glia|October 6, 2005
Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferationSuzana Atanasoski, Danielle Boller, Lukas De Ventura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cellsDanielle Boller, Alexander Schramm, Kathrin T Doepfner, et al.
The Biochemical Journal|May 18, 2007
Novel role for insulin as an autocrine growth factor for malignant brain tumour cellsAlexandre Arcaro, Kathrin T Doepfner, Danielle Boller, et al.
Plos One|April 11, 2014
Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastomaKatrin Höland, Danielle Boller, Christian Hagel, et al.
Anticancer Research|July 31, 2012
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumoursDanielle Boller, Kathrin T Doepfner, Angela De Laurentiis, et al.
Anticancer Research|May 31, 2022
Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine TumoursDanielle Boller, Kathrin T Doepfner, Angela DE Laurentiis, et al.
Pageof 1